|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.65 SEK | +0.58% |
|
+0.58% | +32.67% |
| 06-18 | Lipum AB Completes Multiple Dose Part of the Phase I Clinical Study | CI |
| 05-28 | Lipum AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Lipum AB (publ) reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was SEK 0.496 million compared to SEK 1.58 million a year ago. Net loss was SEK 38.09 million compared to SEK 52.26 million a year ago.
Basic loss per share from continuing operations was SEK 6.
| 1st Jan change | Capi. | |
|---|---|---|
| +32.67% | 17.34M | |
| +2.87% | 94.22B | |
| -4.08% | 37.76B | |
| -13.80% | 32.5B | |
| +73.38% | 27.75B | |
| -11.65% | 16.13B | |
| -0.67% | 14.19B | |
| -11.67% | 11.42B | |
| +190.36% | 11.06B | |
| -52.61% | 9.09B |
LIPUM AB 
